Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZYNE
2826
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $840K | ﹤0.01% |
736,600
+408,200
| +124% | +$520K |
|
2827
Quanterix
QTRX
$139M
| $839K | ﹤0.01% |
51,800
-147,700
| -74% | -$3.04M |
|
2828
Prelude Therapeutics
PRLD
$457M
| $838K | ﹤0.01% |
160,486
+120,386
| +300% | +$613K |
|
|
UXIN
2829
Uxin Ltd
UXIN
$249M
| $835K | ﹤0.01% |
+19,873
| New | +$1.19M |
|
|
CBL
2830
CBL Properties
CBL
$1.77B
| $832K | ﹤0.01% |
+35,400
| New | +$989K |
|
2831
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $832K | ﹤0.01% |
11,200
-41,100
| -79% | -$3.09M |
|
|
VNTR
2832
DELISTED
Venator Materials PLC
VNTR
| $832K | ﹤0.01% |
400,138
+77,400
| +24% | +$158K |
|
2833
Credo Technology Group
CRDO
$50B
| $830K | ﹤0.01% |
71,035
+53,635
| +308% | +$623K |
|
2834
Farmers & Merchants Bancorp
FMAO
$484M
| $829K | ﹤0.01% |
24,981
-3,431
| -12% | -$128K |
|
2835
Perella Weinberg Partners
PWP
$1.28B
| $829K | ﹤0.01% |
142,200
+92,800
| +188% | +$671K |
|
2836
iHeartMedia
IHRT
$450M
| $828K | ﹤0.01% |
104,927
-522,300
| -83% | -$7.04M |
|
|
RAAS
2837
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
| $826K | ﹤0.01% |
262,077
+131,544
| +101% | +$424K |
|
2838
First Trust Dorsey Wright Focus 5 ETF
FV
$3.83B
| $824K | ﹤0.01% |
+19,900
| New | +$922K |
|
2839
Royal Caribbean
RCL
$82.4B
| $824K | ﹤0.01% |
23,600
-116,700
| -83% | -$7.26M |
|
|
SELF
2840
Global Self Storage
SELF
$58.6M
| $824K | ﹤0.01% |
146,300
+11,939
| +9% | +$70.8K |
|
2841
Ultralife
ULBI
$120M
| $822K | ﹤0.01% |
180,589
-10,756
| -6% | -$53K |
|
|
SCTL
2842
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $822K | ﹤0.01% |
1,033,400
+13,400
| +1% | +$14.4K |
|
2843
Interface
TILE
$2.23B
| $821K | ﹤0.01% |
65,500
+38,459
| +142% | +$510K |
|
|
DOMA
2844
DELISTED
Doma Holdings, Inc.
DOMA
| $821K | ﹤0.01% |
31,876
+21,544
| +209% | +$915K |
|
|
BBU
2845
DELISTED
Brookfield Business Partners
BBU
| $820K | ﹤0.01% |
38,700
+6,000
| +18% | +$147K |
|
2846
Comstock Holding Companies
CHCI
$152M
| $819K | ﹤0.01% |
181,164
+1,800
| +1% | +$8.5K |
|
|
ELSE
2847
DELISTED
Electro-Sensors
ELSE
| $811K | ﹤0.01% |
134,200
+2,800
| +2% | +$14.4K |
|
|
AVEO
2848
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $810K | ﹤0.01% |
123,400
+73,800
| +149% | +$357K |
|
|
AFMD
2849
DELISTED
Affimed
AFMD
| $809K | ﹤0.01% |
+29,197
| New | +$1,000K |
|
2850
Mirum Pharmaceuticals
MIRM
$6.02B
| $808K | ﹤0.01% |
41,500
+8,300
| +25% | +$196K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.